NVST Logo

Envista Holdings Corp (NVST) 

NYSE
Market Cap
$3.26B
Sector
Healthcare
Industry
Medical—Equipment & Services
Rank in Sector
152 of 958
Rank in Industry
1 of 2

Largest Insider Buys in Sector

NVST Stock Price History Chart

NVST Stock Performance

About Envista Holdings Corp

Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental …

Insider Activity of Envista Holdings Corp

Over the last 12 months, insiders at Envista Holdings Corp have bought $906,708 and sold $0 worth of Envista Holdings Corp stock.

On average, over the past 5 years, insiders at Envista Holdings Corp have bought $661,893 and sold $18.04M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Keel Paul A (Chief Executive Officer) — $1.01M. Hammes Eric D. (Chief Financial Officer) — $801,215.

The last purchase of 30,000 shares for transaction amount of $506,100 was made by Keel Paul A (Chief Executive Officer) on 2024‑08‑13.

List of Insider Buy and Sell Transactions, Envista Holdings Corp

2024-08-13PurchaseChief Executive Officer
30,000
0.0181%
$16.87$506,1000.00%
2024-08-12PurchaseChief Financial Officer
24,532
0.0144%
$16.33$400,608+17.63%
2023-11-16PurchaseSVP, Orthodontics
2,185
0.0013%
$22.89$50,015-12.27%
2023-11-08PurchaseGeneral Counsel
5,000
0.0029%
$21.75$108,750-6.66%
2023-11-06PurchaseChief Executive Officer
10,000
0.0059%
$21.53$215,253-5.26%
2023-11-06PurchasePrincipal Financial Officer
2,000
0.0012%
$21.53$43,060-5.26%
2023-02-28SaleChief Financial Officer
10,016
0.006%
$37.90$379,606-17.47%
2022-11-17SaleChief Financial Officer
657
0.0004%
$36.55$24,013-6.69%
2022-04-18SaleChief Financial Officer
5,341
0.0033%
$45.73$244,244-16.99%
2022-03-29SaleChief Executive Officer
3,801
0.0025%
$51.50$195,752-22.61%
2022-03-18SaleChief Executive Officer
6,737
0.0041%
$49.75$335,166-23.85%
2022-03-18SaleChief Financial Officer
4,786
0.003%
$50.86$243,416-23.85%
2022-03-18SaleSVP, Strategy & Bus. Dev.
10,092
0.0062%
$50.00$504,600-23.85%
2022-03-16SaleChief Executive Officer
8,982
0.0055%
$47.75$428,891-20.24%
2022-03-01SaleChief Human Resources Officer
4,181
0.0026%
$47.83$199,977-19.50%
2022-03-01SaleSVP, Strategy & Bus. Dev.
2,958
0.0018%
$47.83$141,481-19.50%
2022-02-25SaleChief Financial Officer
7,196
0.0044%
$47.81$344,041-20.93%
2022-02-25SaleChief Human Resources Officer
16,892
0.0102%
$47.71$805,917-20.93%
2022-02-25SaleSVP, Strategy & Bus. Dev.
18,574
0.0112%
$47.65$884,963-20.93%
2022-02-11SaleSVP, Strategy & Bus. Dev.
12,112
0.0076%
$47.50$575,320-17.65%

Insider Historical Profitability

<0.0001%
Keel Paul AChief Executive Officer
402605
0.2339%
$18.9510
Hammes Eric D.Chief Financial Officer
24532
0.0143%
$18.9510
Aghdaei AmirChief Executive Officer
295362
0.1716%
$18.95212<0.0001%
Conley EricSVP, Orthodontics
47376
0.0275%
$18.9510
Bludworth Curt WChief Human Resources Officer
46759
0.0272%
$18.9516<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$442.78M12.0520.71M+13.3%+$51.98M0.01
The Vanguard Group$366.44M9.9717.14M-0.17%-$609,158.960.01
Morgan Stanley$361.43M9.8416.91M+3.81%+$13.26M0.03
Harris Associates$208.66M5.689.76M-10.07%-$23.36M0.34
Ariel Investments$190.12M5.178.89M+25.3%+$38.38M1.87
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.